BIOMAT Database Logo BIOMAT Database Logo

[Prolonged effect against exercise-induced bronchospasm: salmeterol versus sodium cromoglycate]. 1992

J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Service de Pneumologie, Hôpital de la Croix-Rousse, Lyon.

Nineteen subjects with isolated exercise-induced asthma (FEV1, FEF25-75%, PEFR, FVC greater than 95% predicted values, fall in FEV1 of at least 15% after exercise, typical recent symptoms of exercise-induced asthma, no other treatment) were entered in a multicenter trial carried out in a double blind, double placebo, cross-over manner. After a one-month baseline period, subjects underwent an exercise after inhaling 100 micrograms of salmeterol (n = 12) or 40 mg of sodium cromoglycate (n = 7). Treatments were alternated before the second exercise which took place at least 2 days after the first. Efficacy was assessed by examining changes in FEV1, FEF25-75% after exercise carried out 30 minutes and 7 hours after administering the treatment by comparison with baseline values (assessments done 1, 10 and 30 minutes after exercise, lowest of three values kept for the analysis of each parameter). FEV1 and FEF25-75% were significantly higher 30 minutes after taking salmeterol. Salmeterol was found to be superior to sodium cromoglycate for all parameters 7 hours after administering the drug. Both treatments were well tolerated. This study confirms that the longer duration of effect of salmeterol and its superiority by comparison with the standard treatments of exercise-induced asthma.

UI MeSH Term Description Entries
D008297 Male Males
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068299 Salmeterol Xinafoate A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Salmeterol,Serevent,Xinafoate, Salmeterol
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D001250 Asthma, Exercise-Induced Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it). Bronchospasm, Exercise-Induced,Exercise-Induced Asthma,Exercise-Induced Bronchospasm,Asthma, Exercise Induced,Bronchospasm, Exercise Induced,Exercise Induced Asthma,Exercise Induced Bronchospasm,Exercise-Induced Asthmas,Exercise-Induced Bronchospasms

Related Publications

J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.
December 1994, American journal of respiratory and critical care medicine,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
The effect of sodium cromoglycate in preventing aspirin induced bronchospasm.
May 1976, Clinical allergy,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Bronchospasm induced by inhalation of substance P: effect of sodium cromoglycate.
January 1988, Respiration; international review of thoracic diseases,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children--a randomised cross-over study.
September 2003, European journal of medical research,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Inhibition of propranolol-induced bronchospasm by sodium cromoglycate [proceedings].
November 1979, British journal of pharmacology,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review.
January 2001, The European respiratory journal,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
The dose-duration effect of sodium cromoglycate in exercise-induced asthma.
January 1984, Clinical allergy,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Dose-duration effect of sodium cromoglycate aerosol in exercise-induced asthma.
October 1986, European journal of respiratory diseases,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Effect of oral and inhaled sodium cromoglycate in exercise-induced asthma.
June 1980, Allergy,
J C Guérin, and C Brambilla, and P Godard, and H de Muizon, and B Aubert, and J Bons
Change in osmolarity of disodium cromoglycate solution and protection against exercise-induced bronchospasm in children with asthma.
September 1996, The European respiratory journal,
Copied contents to your clipboard!